About the Biodrugs and Biotherapeutics Session
The development of biodrugs and biotherapeutics has revolutionized modern medicine, offering targeted treatments for a wide range of diseases, including cancer, autoimmune disorders, and genetic conditions. Biodrugs, which are derived from living organisms, include monoclonal antibodies, vaccines, and recombinant proteins, all designed to interact with specific molecular targets in the body. These biotherapeutic agents offer highly effective treatment options, often with fewer side effects compared to traditional small molecule drugs. The production of biodrugs requires advanced biotechnological processes, such as cell culture and genetic engineering, to ensure that the products are both safe and effective. As research advances, the scope of biotherapeutics continues to expand, with innovations in gene therapy, cell-based therapies, and personalized medicine paving the way for more effective and individualized treatments. The growing field of biodrugs and biotherapeutics holds immense promise for improving patient outcomes and transforming healthcare.
Featured Speakers — Biodrugs and Biotherapeutics 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Biodrugs and Biotherapeutics Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at PDDS 2027
Why Attend the Biodrugs and Biotherapeutics Conference 2027
Present Your Research
Oral and poster slots for original Biodrugs and Biotherapeutics work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Learn from Keynotes
Plenary lectures from leading voices shaping Biodrugs and Biotherapeutics research and practice.
Hybrid Flexibility
Attend in person in Valencia or join virtually — same program, same certificate.
Join PDDS 2027 for the Biodrugs and Biotherapeutics track
Oral and poster slots for your work — in person in Valencia or online. Not presenting? Attend as a delegate to learn from the field.
Biodrugs and Biotherapeutics Conference 2027 — FAQs
What is the Biodrugs and Biotherapeutics track at PDDS 2027?
The Biodrugs and Biotherapeutics track is a dedicated stream within PDDS 2027 covering the latest research, clinical innovation, and best practice in Biodrugs and Biotherapeutics. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Biodrugs and Biotherapeutics sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Biodrugs and Biotherapeutics are all welcome — whether presenting or attending.
Can I present my research in the Biodrugs and Biotherapeutics track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Is virtual attendance available for Biodrugs and Biotherapeutics sessions?
Yes. PDDS 2027 is a hybrid conference — attend the Biodrugs and Biotherapeutics track in person in Valencia or join live online, with on-demand access afterward.
Join the PDDS 2027 delegation
Valencia · September 13–15, 2027 · Hybrid · in-person & virtual
Attend without presenting.